Masanori Nojima
- Cancer Research top 2%
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research 11
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments 18
- Molecular Biology top 5%
- Epigenetics and DNA Methylation 21
- Cancer-related gene regulation 13
- Gastroenterology top 2%
-
- Prostate Cancer Treatment and Research 14
- Renal cell carcinoma treatment 13
- Gastric Cancer Management and Outcomes 10
-
- Inflammatory Bowel Disease 11
- Co-authors
- Hiromu SuzukiTakashi TokinoYasuhisa ShinomuraReo MaruyamaMinoru ToyotaKohzoh ImaiYasushi SasakiMitsuru Mori
- Journals
- The Journal of Experimental Medicine (1 paper)Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (5 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Masanori Nojima
305 papers receiving 5.3k citations
Peers
Comparison fields: 5 of 142
- Cancer Research 781
- Oncology 1.2k
- Transplantation 118
- Molecular Biology 2.3k
- Gastroenterology 181
Countries citing papers authored by Masanori Nojima
This map shows the geographic impact of Masanori Nojima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masanori Nojima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masanori Nojima more than expected).
Fields of papers citing papers by Masanori Nojima
This network shows the impact of papers produced by Masanori Nojima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masanori Nojima. The network helps show where Masanori Nojima may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Masanori Nojima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2022 | 1 | |
| 4 | 2022 | 21 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 3 | |
| 7 | 2021 | 9 | |
| 8 | 2019 | 12 | |
| 9 | 2019 | 6 | |
| 10 | 2019 | 11 | |
| 11 | 2017 | 1 | |
| 12 | 2017 | 8 | |
| 13 | 2012 | 32 | |
| 14 | 2011 | 135 | |
| 15 | 2010 | 75 | |
| 16 | 2009 | 53 | |
| 17 | Relationship of serum superoxide dismutase activity and lifestyle in healthy Japanese adults. | 2009 | 10 |
| 18 | 2008 | 203 | |
| 19 | [SFRP, a family of new colorectal tumor suppressor candidate genes]. | 2005 | 11 |
| 20 | 1995 | 3 |
About Masanori Nojima
Masanori Nojima is a scholar working on Transplantation, Hematology and Oncology, having authored 322 papers that have together received 5.4k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (21 papers), Renal Transplantation Outcomes and Treatments (18 papers), Prostate Cancer Treatment and Research (14 papers), Renal cell carcinoma treatment (13 papers), Cancer-related gene regulation (13 papers), Inflammatory Bowel Disease (11 papers), Pancreatic and Hepatic Oncology Research (11 papers) and Gastric Cancer Management and Outcomes (10 papers). The work is most often cited by research in Cancer Research (781 citations), Oncology (1.2k citations) and Transplantation (118 citations). Masanori Nojima has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Hiromu Suzuki, Takashi Tokino, Yasuhisa Shinomura, Reo Maruyama, Minoru Toyota, Kohzoh Imai, Yasushi Sasaki, Mitsuru Mori, Eiichiro Yamamoto and Masahiro Kai. Their work appears in journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.